BridgeBio Pharma, Inc.BBIONASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
9.17%
↓ 99% below average
Average (30q)
984.09%
Historical baseline
Range
High:11998.57%
Low:-100.00%
Volatility
1229.4%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 9.17% |
| Q2 2025 | -5.20% |
| Q1 2025 | 1882.88% |
| Q4 2024 | 115.30% |
| Q3 2024 | 26.01% |
| Q2 2024 | -98.97% |
| Q1 2024 | 11998.57% |
| Q4 2023 | -57.35% |
| Q3 2023 | 149.30% |
| Q2 2023 | -10.13% |
| Q1 2023 | -2.35% |
| Q4 2022 | 453.25% |
| Q3 2022 | -99.54% |
| Q2 2022 | 4253.36% |
| Q1 2022 | -86.85% |
| Q4 2021 | 449.74% |
| Q3 2021 | -95.66% |
| Q2 2021 | 11593.51% |
| Q1 2021 | 278.69% |
| Q4 2020 | -98.50% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | -100.00% |
| Q4 2019 | -48.32% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |